EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of novel potent dual Mer/c-Met inhibitors based on structural optimization

Lihong Duan, Xiaoyu Meng, Fang Li, Chen Wang, Ying Wu, Daowei Huang, Zhiwei Li

Bioorganic & Medicinal Chemistry Letters · 2026

DOI: 10.1016/j.bmcl.2025.130415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026. Verfasst von Lihong Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: The fourth hospital of Shijiazhuang, Shijiazhuang 050000, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Drug Design, Protein Kinase Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Hebei University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mer and c-Met kinases are frequently co-overexpressed in diverse malignancies, where their concurrent inhibition offers potential for synergetic antitumor efficacy while mitigating toxicity risks associated with single-target therapy. Building upon our previously identified lead compound, we designed and synthesized novel derivatives targeting dual Mer/c-Met inhibition. Among these, compound 17j emerged as a potent dual inhibitor, demonstrating IC50 values of 1.00 ± 0.14 nM (Mer) and 19.00 ± 3.23 nM (c-Met). This agent exhibited robust antiproliferative activity against HCT116, A2780, and PC-3 cancer cell lines, coupled with favorable safety profiles including hERG liability. Notably, 17j displayed exceptional metabolic stability in human liver microsomes (t1/2 = 72.6 min) over compound 17c. Mechanistic studies confirmed its dose-dependent cytotoxicity and significant suppression of HCT116 cell migration. Collectively, these findings position 17j as a promising therapeutic candidate for Mer/c-Met driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-metDrug DesignProtein Kinase InhibitorsAntineoplastic AgentsReceptor Protein-Tyrosine KinasesHumansStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorMolecular StructureCell Line, TumorDose-Response Relationship, DrugMicrosomes, Liverc-Mer Tyrosine Kinase

Stichwörter der Autor:innen

Anti-cancerDual inhibitorMer kinaseStructural optimizationc-Met kinase

Substanzen

Proto-Oncogene Proteins c-metProtein Kinase InhibitorsAntineoplastic AgentsMERTK protein, humanReceptor Protein-Tyrosine Kinasesc-Mer Tyrosine Kinase

Autor:innen und Institutionen

  • The fourth hospital of Shijiazhuang, Shijiazhuang 050000, China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China. Electronic address: huangdaowei321@163.com.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China. Electronic address: lizhiwei@hebust.edu.cn.

Förderung

  • Hebei University of Science and Technology

Zitieren

APA

Duan, L., Meng, X., Li, F., Wang, C., Wu, Y., Huang, D., & Li, Z. (2026). Design, synthesis, and biological evaluation of novel potent dual Mer/c-Met inhibitors based on structural optimization. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2025.130415

Vancouver

Duan L, Meng X, Li F, Wang C, Wu Y, Huang D, et al. Design, synthesis, and biological evaluation of novel potent dual Mer/c-Met inhibitors based on structural optimization. Bioorganic & Medicinal Chemistry Letters. 2026. doi:10.1016/j.bmcl.2025.130415

BibTeX
@article{Duan2026,
  author = {Duan, Lihong and Meng, Xiaoyu and Li, Fang and Wang, Chen and Wu, Ying and Huang, Daowei and Li, Zhiwei},
  title = {Design, synthesis, and biological evaluation of novel potent dual Mer/c-Met inhibitors based on structural optimization},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  doi = {10.1016/j.bmcl.2025.130415}
}
Kostenlos starten →